News

Relay Therapeutics Gears Up for Investor Engagements This Month

Relay Therapeutics Gears Up for Investor Engagements This Month

Relay Therapeutics Announces Key Investor Conference Participation

Relay Therapeutics, Inc. (NASDAQ: RLAY), a pioneering company in the field of clinical-stage precision medicine, is gearing up to participate in two significant investor conferences this month. This initiative highlights their commitment to engage with the investment community and share developments related to their groundbreaking therapies aimed at treating cancer and genetic diseases.

Details of Upcoming Conferences

The two investor conferences where Relay Therapeutics' management team will be present include:

Wells Fargo Healthcare Conference

Scheduled for September 4, 2025, this highly anticipated conference offers Relay’s leadership a platform to discuss their innovative strategies and recent advancements. Management will take the stage at 2:15 p.m. ET, presenting insights into their pipeline.

Morgan Stanley 23rd Annual Global Conference

Following closely, Relay will participate in the Morgan Stanley 23rd Annual Global Conference on September 10, 2025, at 11:30 a.m. ET. Here, the company will further delve into its mission and highlight ongoing clinical research efforts focused on the development of its therapies.

Webcast Access and Archival Information

Both fireside chats will be accessible via live stream, allowing investors and interested parties to tune in from anywhere. The webcasts can be found on the Relay Therapeutics website under the Events section. For those unable to attend live, an archive of the presentations will be available for up to 30 days after the events.

About Relay Therapeutics

Relay Therapeutics, known for its cutting-edge Dynamo platform, focuses on redefining precision medicine. This platform uniquely integrates advanced computational methods with experimental approaches to target proteins that have long been challenging to treat. Among their notable projects, the lead asset, RLY-2608, stands out as the first of its kind—a pan-mutant selective PI3K? inhibitor currently undergoing a Phase 3 clinical trial specifically for HR+/HER2- metastatic breast cancer. Moreover, the company is expanding its efforts into PI3K?-driven vascular malformations and developing therapies for NRAS-driven solid tumors and Fabry disease—further enhancing its diverse clinical pipeline.

Contact Information for Further Inquiries

For any additional information, interested parties are encouraged to reach out directly to Pete Rahmer. His contact details are as follows:

Pete Rahmer
Email: prahmer@relaytx.com

Media Relations

For media inquiries, please contact Dan Budwick at 1AB, reachable via phone at 973-271-6085 or through email at dan@1abmedia.com.

Frequently Asked Questions

1. What is Relay Therapeutics' core mission?

Relay Therapeutics is dedicated to developing innovative precision therapies for patients with cancer and genetic disorders.

2. When are the two investor conferences scheduled?

The Wells Fargo Healthcare Conference is set for September 4, 2025, and the Morgan Stanley Global Conference will take place on September 10, 2025.

3. How can I access the webcasts of the conferences?

Webcasts will be available live on Relay Therapeutics' website, and recordings will be accessible for 30 days post-event.

4. What is RLY-2608?

RLY-2608 is Relay Therapeutics' lead clinical asset, a selective PI3K? inhibitor in advanced clinical trials for treating specific breast cancer patients.

5. Who can I contact for more information?

For further details, you can contact Pete Rahmer via email at prahmer@relaytx.com.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

APP Group's New Conservation Efforts in Sumatra

Updated Category News Views 0

Taking a Bold Step Towards Conservation APP Group, in collaboration with Proforest, WWF-Indonesia, and KKI WARSI, is setting its sights on a more sustainable future with the PROTECT30 initiative. This isn't just another dime-a-dozen CSR project—it’s a concerted effort aimed at conserving Sumatra's precious Bukit Tigapuluh landscape. These folks are playing the long...

Continue Reading
Pen Needles Market to Hit $3.37B by 2031: Growth Ahead

Updated Category News Views 99

Big Numbers in the Needle Game When you're staring down the numbers popping out of this pen needles market projection, it's hard to ignore—shooting from a respectable $2.16 billion in 2026 to a hefty $3.37 billion by 2031. We're talking a 9.3% CAGR that'll have investors pulling out their calculators or maybe rubbing their hands in downright glee, depending on their...

Continue Reading
Maxwell M1 Hybrid Unveils Game-Changing Aircraft

Updated Category News Views 122

Welcome to the Future of Amphibious Flight You ever wonder when we'd get past seeing traditional planes stuck at runways? Well, Maxwell Aircraft just fired a hefty shot across the bow with their M1 Hybrid amphibious model. This ain't your run-of-the-mill crate with wings; it's redefining what these birds can do, particularly if you're eyeing remote areas or water-based...

Continue Reading
ANDPAD Shines in Asia's 2026 Growth Company Awards

Updated Category News Views 85

AI Takes Center Stage in Construction Ever seen AI shake a dusty old industry to its core? Well, if you haven't, ANDPAD is doing just that in construction, making waves across Asia. Look, when a company like ANDPAD snags a spot in the 'NextGen Tech 30 2026,' you pay attention. That's a glitzy award for the movers and shakers in tech, and these folks are doing some serious...

Continue Reading
Crunch Fitness Invests $5M in Jurupa Valley Expansion

Updated Category News Views 54

New Era for Crunch Fitness in Jurupa Valley When you've been around the block as much as some of us have, you learn to spot the makings of a solid investment. Fitness Ventures isn't just tossing another gym into the sea of treadmills and barbells; they're making waves with their new $5 million Crunch 3.0 club in Jurupa Valley. This isn't some half-baked, pop-up fitness...

Continue Reading
Teneo Expands Financial Advisory in Canada, Eyes Talent

Updated Category News Views 48

Turning the Maple Leaf Over: Teneo's Move Alright, here's the scoop: Teneo is muscling its way north, into Canada, to flex its Financial Advisory chops. With a lineup of 60 professionals already setting the pace across Toronto, Montreal, and Calgary, this move isn’t just smoke—it’s a full-fledged expansion. They're under the hood, tinkering away to beef up...

Continue Reading
Dr. Rod Rohrich Tops Facelift Surgeons Once Again

Updated Category News Views 57

A Consistent Top Performer in the Cosmetic Surgery World When the same name pops up as the best in their field year after year, it's not just luck—it's a testament to their skills and dedication. Newsweek has ranked Dr. Rod J. Rohrich as the top facelift surgeon in the U.S. for six consecutive years. Now that’s one heck of a streak in the cutthroat world of cosmetic...

Continue Reading
FX's Game-Changer: Stemless Reverse Shoulder System

Updated Category News Views 162

Stirring Up the Shoulder Market You gotta hand it to FX Shoulder Solutions – they've managed to elbow their way into the medical device market with something truly revolutionary. With the FDA clearance of Easytech Reversed®, a stemless reverse shoulder arthroplasty system, they're not just playing the innovation game; they're setting a whole new rulebook. This isn't...

Continue Reading
NextPlat Gears Up for Q3 2026 Earnings Call

Updated Category News Views 32

NextPlat's Upcoming Financial Revelation November is shaping up to be a month of revelations for NextPlat Corp (NASDAQ:NXPL) as they prepare to spill the beans on their third-quarter 2026 financials. The number crunching wraps up at 8:30 a.m. Eastern on November 12, when the execs will host an investor conference call. The Details of the Big Day Coming to you live from...

Continue Reading
Brian Long Exits Atlantic Bridge for US Tech Fund

Updated Category News Views 134

Well, here we go again with another shake-up in the tech investment world. Brian Long, a name that's been whispered around more than a few boardroom tables, is dropping out of Atlantic Bridge to start his own gig across the pond in the United States. If you're tracking numbers, Atlantic Bridge is juggling a healthy €1.4bn in assets—no small potatoes. So, let's dig...

Continue Reading

Top 5 Most Recently Viewed Articles

Dell Stock Gains Ahead of Fourth-Quarter Earnings Report

Updated Category News Views 222

Hot Buzz on Dell Technologies Gave a little kick to the stock today, didn’t it? Dell Technologies Inc. (NYSE:DELL) saw its stock take a leap on Wednesday, just a day before its fourth-quarter earnings report drops like a hot mixtape. Set your reminders; they’re clocking in after the market closes on Thursday, February 26. Investors are sitting tight, keen to grab the...

Continue Reading
Understanding Recent Market Indicators for Fidelity National Finl

Updated Category News Views 147

Current Market Sentiment Around Fidelity National Finl Fidelity National Finl (NYSE: FNF) has seen a significant decrease in its short percent of float, dropping by 13.62% since the last report. Recently, the company disclosed that it has approximately 4.00 million shares sold short, representing 1.84% of its total regular shares available for trading. For traders, this...

Continue Reading
Growth Journey of Plant-Based Dairy: Trends and Insights

Updated Category News Views 252

Exploring the Plant-Based Dairy Products Market The plant-based dairy products market is witnessing remarkable growth, driven by evolving consumer preferences and increasing awareness regarding health benefits and sustainability practices. Initially valued at USD 20 billion, market experts project it to reach USD 34 billion by 2030, fueled by a promising CAGR of 9%...

Continue Reading
AnaChart Reveals Exceptional Analysts of 2024 in Finance

Updated Category News Views 355

AnaChart's Recognition of Leading Analysts in 2024 AnaChart, a New York-based Fintech company, has launched its annual recognition of standout stock research analysts for 2024. This year, they have acknowledged the analysts whose insights and forecasts provided crucial guidance in the fast-paced world of finance. Utilizing an innovative algorithm, AnaChart has evaluated...

Continue Reading
Draganfly Secures Agreement with U.S. Army for Drone Innovations

Updated Category News Views 199

Draganfly Partners with U.S. Army for Advanced Drone Systems Draganfly Inc. (NASDAQ: DPRO) has recently been chosen by the U.S. Army to deliver its innovative Flex FPV drone systems. This initiative encompasses not just the supply of the drones but also the establishment of onsite manufacturing, comprehensive training, and secure logistics support tailored for military...

Continue Reading